Birdwatch Archive

Birdwatch Note

2023-03-11 01:28:02 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING

The latest Cochrane Review points to Ivermectin being an ineffective treatment for Covid-19. A very big doses would be needed in humans to have the effects shown in lab tests. https://www.evidentlycochrane.net/treatments-for-mild-covid-19-cochrane-evidence/#anchor-627391eb6sfa https://jamanetwork.com/journals/jama/fullarticle/2801828 https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full

Written by 71EB268E7A8F69DFC819CAAE0A760DFD1B895A145E18F142043E0C9900DB4061
Participant Details

Original Tweet

Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1633855423580106752

Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.

All Information

  • ID - 1634365530323705857
  • noteId - 1634365530323705857
  • participantId - 71EB268E7A8F69DFC819CAAE0A760DFD1B895A145E18F142043E0C9900DB4061
  • noteAuthorParticipantId -
  • createdAtMillis - 1678498082128
  • tweetId - 1633855423580106752
  • classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
  • believable -
  • harmful -
  • validationDifficulty -
  • misleadingOther - 0
  • misleadingFactualError - 0
  • misleadingManipulatedMedia - 0
  • misleadingOutdatedInformation - 0
  • misleadingMissingImportantContext - 1
  • misleadingUnverifiedClaimAsFact - 0
  • misleadingSatire - 0
  • notMisleadingOther - 0
  • notMisleadingFactuallyCorrect - 0
  • notMisleadingOutdatedButNotWhenWritten - 0
  • notMisleadingClearlySatire - 0
  • notMisleadingPersonalOpinion - 0
  • trustworthySources - 1
  • summary
    • The latest Cochrane Review points to Ivermectin being an ineffective treatment for Covid-19. A very big doses would be needed in humans to have the effects shown in lab tests. https://www.evidentlycochrane.net/treatments-for-mild-covid-19-cochrane-evidence/#anchor-627391eb6sfa https://jamanetwork.com/journals/jama/fullarticle/2801828 https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD015017.pub3/full

Note Status History

createdAt timestampMillisOfFirstNonNMRStatus firstNonNMRStatus timestampMillisOfCurrentStatus currentStatus timestampMillisOfLatestNonNMRStatus mostRecentNonNMRStatus participantId
2023-03-11 01:28:02 UTC
(1678498082128)		 1969-12-31 23:59:59 UTC
(-1)		 2023-03-13 02:08:35 UTC
(1678673315039)		 NEEDS_MORE_RATINGS 1969-12-31 23:59:59 UTC
(-1)

Note Ratings

rated at rated by
2023-03-11 10:16:27 -0600 0A2C1448069F7393CA659AE01CDAC943B9B767F88A8E5ED3CA02918A63A24356 Rating Details
2023-03-11 21:36:08 -0600 3871C986B3C2BCF97D13633DBD3E4A728BFB2C0C9317A7E7E2E70475092E58E0 Rating Details
2023-03-11 11:53:21 -0600 45060ED935D102E05C21C743FE433C0B17B27D8FCF69CED01A2AD3F9AB2815B1 Rating Details
2023-03-11 19:47:32 -0600 464F514091F013106E190C712492FDDD7A2F35D38B0E762F31374CC21B9FD858 Rating Details
2023-03-10 20:10:16 -0600 5B66C2C2840AD455FDAC3D1F25BF92AD35DB04D16E6BE11F99C2E62BAC83F418 Rating Details
2023-03-11 13:09:16 -0600 648BE6EE6413CB1DE7ED8A8A5637E417455500360B820CE820E3A4FD4EC19130 Rating Details
2023-03-11 21:05:57 -0600 72A59FB5955991E68C6349DA62C35A734500BE2AEFDA828D7BB704AB0E76465C Rating Details
2023-03-11 11:49:22 -0600 7DAF7E766C91C4681BD9E35A65ED1244CD021FD7E551BF6AB85D6DF31D7EAC10 Rating Details
2023-03-11 10:15:43 -0600 81FE9D7D2F668CA266451363352D22DBEFD24221ED5A9EB621D5542E5311974D Rating Details
2023-03-10 20:37:22 -0600 835141A7850248566093990F209A5121FAC8DEB69437093D6392C24B923E6896 Rating Details
2023-03-11 10:05:05 -0600 AA4BEAF3AB69D0807295F3D4E5F9D50FC49A82AE25BE220271F7B42AE4275BC9 Rating Details
2023-03-11 19:37:53 -0600 B289B7B9A72A2B21A5016714B5CFECC892B67D4EF528AD49D229201250F7B83A Rating Details
2023-03-11 03:00:01 -0600 C378931E048482D2BFDF00DC95644D6377CBCB812C79FF87D77B5E48595B3DA3 Rating Details
2023-03-17 06:41:21 -0500 Rating Details
2023-03-11 16:41:38 -0600 Rating Details
2023-03-11 10:15:43 -0600 Rating Details
2023-03-11 10:16:27 -0600 Rating Details
2023-03-11 03:00:01 -0600 Rating Details
2023-03-11 11:53:21 -0600 Rating Details
2023-03-11 21:36:08 -0600 Rating Details
2023-03-11 11:49:22 -0600 Rating Details
2023-03-11 13:09:16 -0600 Rating Details
2023-03-10 20:10:16 -0600 Rating Details
2023-03-11 21:05:57 -0600 Rating Details
2023-03-11 19:47:32 -0600 Rating Details
2023-03-11 19:37:53 -0600 Rating Details
2023-03-11 16:41:38 -0600 Rating Details
2023-03-10 20:37:22 -0600 Rating Details
2023-03-11 10:05:05 -0600 Rating Details
2023-03-17 06:41:21 -0500 Rating Details